UBS O'Connor’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,909
| Closed | -$33.6K | – | 368 |
|
|
2025
Q1 | $33.6K | Sell |
3,909
-12,492
| -76% | -$107K | ﹤0.01% | 240 |
|
|
2024
Q4 | $586K | Sell |
16,401
-6,400
| -28% | -$229K | 0.02% | 259 |
|
|
2024
Q3 | $1.08M | Buy |
22,801
+1,029
| +5% | +$48.6K | 0.03% | 266 |
|
|
2024
Q2 | $1.09M | Buy |
21,772
+4,400
| +25% | +$221K | 0.03% | 280 |
|
|
2024
Q1 | $1.95M | Sell |
17,372
-4,854
| -22% | -$544K | 0.06% | 176 |
|
|
2023
Q4 | $1.29M | Buy |
22,226
+10,369
| +87% | +$601K | 0.04% | 238 |
|
|
2023
Q3 | $376K | Buy |
+11,857
| New | +$376K | 0.01% | 405 |
|
|
2023
Q2 | – | Sell |
-18,508
| Closed | -$1.9M | – | 567 |
|
|
2023
Q1 | $1.9M | Buy |
+18,508
| New | +$1.9M | 0.05% | 324 |
|
|
2022
Q4 | – | Sell |
-15,060
| Closed | -$2.55M | – | 192 |
|
|
2022
Q3 | $2.55M | Sell |
15,060
-4,582
| -23% | -$774K | 0.03% | 486 |
|
|
2022
Q2 | $2.27M | Buy |
+19,642
| New | +$2.27M | 0.02% | 618 |
|